Neill Liptrott at University of Liverpool - Research Interests, Publications & Academic Profile

Neill Liptrott

Reader in Pharmacology and Immunocompatibility

University of Liverpool

United Kingdom

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Immunology

60%

Cell Biology

20%

Inflammatory Biology

30%

Drug Delivery

20%

Macrophage Biology

20%

Stem Cell Research

20%

In Vitro Studies

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Building a UK IntraCellular Drug Delivery Centre (ICDDC)

Open Date: 2023-01-01

Close Date:

Grant: Open

SINPAIN: A game changer for the treatment of osteoarthritis: a cost effective combined advanced therapy to treat knee osteoarthritis (SINPAIN)

Open Date: 2022-04-30

Close Date: 2026-10-31

Grant: Close

Multi-modal high resolution preclinical PET+SPECT+CT scanner

Open Date: 2018-07-01

Close Date: 2023-07-01

Grant: Close

Bioengineered substrates for human pluripotent stem cell culture

Open Date: 2016-11-01

Close Date: 2018-10-31

Articles10

Age-differential CD13 and interferon expression in airway epithelia affect SARS-CoV-2 infection - Effects of vitamin D

Article Link

Year:

2023

Fate of intravenously administered umbilical cord mesenchymal stromal cells and interactions with the host's immune system

Article Link

Year:

2023

Intravenous Administration of Human Umbilical Cord Mesenchymal Stromal Cells Leads to an Inflammatory Response in the Lung

Article Link

Year:

2023

Linear and branched polymer prodrugs of the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine as structural materials for long-acting implants

Article Link

Year:

2022

Firefly luciferase offers superior performance to AkaLuc for tracking the fate of administered cell therapies

Article Link

Year:

2022

Exposure of human immune cells, to the antiretrovirals efavirenz and lopinavir, leads to lower glucose uptake and altered bioenergetic cell profiles through interactions with SLC2A1

Article Link

Year:

2022

Exposure of the Basophilic Cell Line KU812 to Liposomes Reveals Activation Profiles Associated with Potential Anaphylactic Responses Linked to Physico-Chemical Characteristics

Article Link

Year:

2022

An inter-laboratory comparison of an NLRP3 inflammasome activation assay and dendritic cell maturation assay using a nanostructured lipid carrier and a polymeric nanomedicine, as exemplars.

Article Link

Year:

2022

Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances.

Article Link

Year:

2022

Assessment of changes in autophagic vesicles in human immune cell lines exposed to nano particles

Article Link

Year:

2021

Collaborators8

Christian M. Hedrich

UNITED KINGDOM

Paul McNamara

Professor in Child Health

University of Liverpool

UNITED KINGDOM

Arthur Taylor

University of Liverpool

UNITED KINGDOM

Patricia Murray

Professor of stem cell biology and regenerative medicine

University of Liverpool

UNITED KINGDOM

Bettina Wilm

Senior Lecturer

University of Liverpool

UNITED KINGDOM

Amy Chadwick

Lecturer

University of Liverpool

UNITED KINGDOM

Tom McDonald

Reader in Sustainable Materials

The University of Manchester

UNITED KINGDOM

Giancarlo Biagini

Deputy Head of Department (Professor)

Liverpool School of Tropical Medicine

UNITED KINGDOM